Tech Company Financing Transactions

IDEAYA Biosciences Funding Round

6 Dimensions Capital, BVF Partners and Nextech Invest participated in a $94 million Series B venture round for IDEAYA Biosciences. The round was announced on 3/16/2018.

Transaction Overview

Company Name
IDEAYA Biosciences
Announced On
3/16/2018
Transaction Type
Venture Equity
Amount
$94,000,000
Round
Series B
Investors

6 Dimensions Capital (Lead Investor) (Edward Hu)

BVF Partners (Lead Investor) (Kanishka Pothula)

Nextech Invest (Lead Investor) (Thilo Schroeder)

Perceptive Advisors (Lead Investor)

5AM Ventures (John Diekman)

Alexandria Venture Investments

Boxer Capital

Canaan Partners (Timothy Shannon)

Celgene

Driehaus Capital Management

GV (Vineeta Agarwala)

Roche Venture Fund (Nisha Marathe)

WuXi Healthcare Ventures

Proceeds Purpose
Utilizing proceeds from the financing, IDEAYA will advance its pipeline with a goal of initiating multiple clinical studies in 2019.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
7000 Shoreline Ct. 350
San Francisco, CA 94080
USA
Phone
(650) 443-6209
Website
www.ideayabio.com
Email Address
[email protected]
Overview
IDEAYA Biosciences (Nasdaq: IDYA). At the core of a successful big biology and small molecule based drug discovery company is well understood pathobiology of the drug targets and excellent chemical matter to modulate them - one without the other ultimately equals failure.
Profile
IDEAYA Biosciences LinkedIn Company Profile
Social Media
IDEAYA Biosciences Company Twitter Account
Company News
IDEAYA Biosciences News
Facebook
IDEAYA Biosciences on Facebook
YouTube
IDEAYA Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Yujiro Hata
  Yujiro Hata LinkedIn Profile  Yujiro Hata Twitter Account  Yujiro Hata News  Yujiro Hata on Facebook
Chief Medical Officer
Julie Hambleton
  Julie Hambleton LinkedIn Profile  Julie Hambleton Twitter Account  Julie Hambleton News  Julie Hambleton on Facebook
Chief Scientific Officer
Michael Dillon
  Michael Dillon LinkedIn Profile  Michael Dillon Twitter Account  Michael Dillon News  Michael Dillon on Facebook
Controller
Andres Briseno
  Andres Briseno LinkedIn Profile  Andres Briseno Twitter Account  Andres Briseno News  Andres Briseno on Facebook
VP - General Counsel
Paul Stone
  Paul Stone LinkedIn Profile  Paul Stone Twitter Account  Paul Stone News  Paul Stone on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/16/2018: Foxtrot venture capital transaction
Next: 3/16/2018: Strix Leviathan venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.